| Style | Citing Format |
|---|---|
| MLA | Alfiel A, et al.. "Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis." Therapeutic Advances in Urology, vol. 18, no. , 2026, pp. -. |
| APA | Alfiel A, Mohammadi A, Mahdi Mehrabi M, Ashtari S, Alaedini F, Guitynavard F, Nikoofar P, Aghamir S M K (2026). Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis. Therapeutic Advances in Urology, 18(), -. |
| Chicago | Alfiel A, Mohammadi A, Mahdi Mehrabi M, Ashtari S, Alaedini F, Guitynavard F, Nikoofar P, Aghamir S M K. "Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis." Therapeutic Advances in Urology 18, no. (2026): -. |
| Harvard | Alfiel A et al. (2026) 'Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis', Therapeutic Advances in Urology, 18(), pp. -. |
| Vancouver | Alfiel A, Mohammadi A, Mahdi Mehrabi M, Ashtari S, Alaedini F, Guitynavard F, et al.. Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis. Therapeutic Advances in Urology. 2026;18():-. |
| BibTex | @article{ author = {Alfiel A and Mohammadi A and Mahdi Mehrabi M and Ashtari S and Alaedini F and Guitynavard F and Nikoofar P and Aghamir S M K}, title = {Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis}, journal = {Therapeutic Advances in Urology}, volume = {18}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Alfiel A AU - Mohammadi A AU - Mahdi Mehrabi M AU - Ashtari S AU - Alaedini F AU - Guitynavard F AU - Nikoofar P AU - Aghamir S M K TI - Predisposing Factors for Angioembolization in Persistent Hematuria After Percutaneous Nephrolithotomy: A Retrospective Analysis JO - Therapeutic Advances in Urology VL - 18 IS - SP - EP - PY - 2026 ER - |